Notably, measuring expression of these cytokines in dystrophic myotubes from DMD patients showed reduced levels of TNFα and IL‐6 upon CYTORexon2,m1Ψ treatment (Figure S2B, Supporting Information). This evidence concerns the gene TNF and Duchenne muscular dystrophy.